Type III secretion pathway in Aeromonas salmonicida and uses therefor

ABSTRACT

Disclosed is a newly identified and characterized type III secretion system in  Aeromonas salmonicida . The invention also encompasses the use of components of the novel secretion system in immunoprotection against  A. salmonicida  infection, as well as other diagnostic and therapeutic uses thereof.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a Divisional of U.S. application Ser. No. 11/529,400, filed Sep. 29, 2006, now U.S. Pat. No. 7,538,208, which is a Divisional of U.S. application Ser. No. 10/813,908, filed Mar. 26, 2004, now U.S. Pat. No. 7,232,569, which is a Continuation of U.S. application Ser. No. 10/416,902, filed May 15, 2003, now abandoned, which is a 371 of International Application No. PCT/CA01/01589, filed Nov. 15, 2001, which claims the benefit of U.S. Provisional Application No. 60/248,864, filed Nov. 15, 2000, each of which is herein incorporated by reference in its entirety.

FIELD OF THE INVENTION

This invention relates to bacterial secretion systems, and in particular to a newly identified and characterized type III secretion system in Aeromonas salmonicida. The invention also encompasses the use of components of the novel secretion system in immunoprotection against A. salmonicida infection, as well as other diagnostic and therapeutic uses thereof.

BACKGROUND OF THE INVENTION

Various publications are referenced throughout this publication, and full citations for each of these publications are provided at the end of the Detailed Description.

Aeromonas salmonicida, a Gram-negative, facultatively anaerobic, non-motile, rod shaped bacterium, growing at temperatures around 20° C., is the etiological agent of furunculoses in salmonids, causing most severe economic losses in production farms of salmon and trout. The disease is characterized in the sub-acute or chronic form by the presence of haemorrhagic necrotic lesions in the gills, gut and muscle, while in the acute form fish die apparently from toxaemia without showing particular external signs.

Due to the high contagiousity of the disease and the high mortality in salmon of all ages, particularly in the sea water growers, large amounts of antibiotics are used in closed and open waters for therapy of furunculoses (Munro and Hastings, 1993). Vaccination has become an important strategy to control furunculoses in fish farms (Ellis, 1997). However, the currently applied whole cell antigen vaccines seem to show considerable variability in efficacy, the origin of which remains currently unexplained (Thornton et al., 1993).

Knowledge of the mechanisms of pathogenicity of A. salmonicida, and in particular of the main virulence factors involved, is essential in the development of efficient strategies to prevent outbreaks of furunculoses caused by A. salmonicida. Currently, several potential virulence factors of A. salmonicida have been reported, including a surface-layer protein (Chu et al., 1991), the hemolysins ASH1, ASH3, ASH4 (Hirono and Aoki, 1993), salmolysin (Titball and Munn, 1985), the serine protease AspA (Whitby et al., 1992) and the glycerolipid-cholesterol acyltransferase (GCAT) (Lee and Ellis, 1990), but their role in pathogenesis is unclear and many of them seem not to play a primary role in virulence. This was demonstrated by A. salmonicida strains with deletion mutants of the GCAT and aspA genes which had no influence on virulence of the strains in inducing furunculoses.

SUMMARY OF THE INVENTION

A new ADP-ribosylating toxin named AexT (Aeromonas exoenzyme T) encoded by the gene aexT was identified in a virulent strain of A. salmonicida. A. salmonicida strains that were propagated for several passages on culture medium had lost expression of AexT, but still retained the aexT gene. AexT shows amino acid sequence similarity to the ADP-ribosyltransferase toxins ExoS and ExoT of Pseudomonas aeruginosa which are secreted by a type III-dependent secretion mechanism (Yahr et al., 1996). Regulation of aexT was shown to be dependent on contact with fish cells and could also be induced by Ca²⁺ depletion of the medium. The aexT gene was found to be preceded by a consensus sequence for binding of a transcriptional activator known in P. aeruginosa as ExsA which is involved in type III mediated gene expression (Frank, 1997).

Based on these observations, we used broad range gene probes to identify in A. salmonicida a novel type III secretion system by means of the gene acrD (Aeromonas calcium response D) encoding a transmembrane spanning protein. The acrD gene has a high similarity to IcrD, a protein of the Yersinia sp. which is an inner membrane protein of the type III secretion apparatus in Yersinia sp. The acrD gene is flanked by further typical type III secretion genes which were designated acr1, acr2, acr3, acr4, acrD, acrR, acrG, acrV, and acrH, and which show significant similarity to pcr1, pcr2, pcr3, pcr4, pcrD, pcrR, pcrG, pcrV, and pcrH of Pseudomonas aeruginosa and to tyeA, sycN, yscX, yscY, lcrD, lcrR, lcrG, IcrV, and IcrH of Yersinia enterocolitica. All these genes play a predominant role in building up the type III secretion apparatus in the respective bacterium, including the regulation of the low calcium response (LCR) and chaperon functions. The genes isolated from A. salmonicida belong to the analogue of the virA operon, which is central in the type III secretion pathway of many Gram-negative pathogens of human, animals and plants (Fenselau et al., 1992; Gough et al., 1992; Michiels and Cornelis, 1991).

We have also determined that the type III secretion system in A. salmonicida is located on a 84 kb plasmid which is rapidly lost upon growth in culture medium. Biosynthesis of AcrV in A. salmonicida, the analogue to LcrV in Yersinia, requires as a trigger either low Ca²⁺ conditions or contact with fish cells. Upon infection with A. salmonicida expressing AcrV, the cultured cells undergo significant morphological changes. Cultures derived from originally virulent A. salmonicida strains, which had lost the type III secretion genes including AcrV, lost virulence as they did not affect rainbow trout gonad cells morphologically after infection. Concomitantly to loss of the type III secretion genes, these cultures lost the expression of the aexT gene which specifies the ADP-ribosylating toxin of A. salmonicida.

Rainbow trout gonad cells infected with the virulent A. salmonicida and incubated in antiserum directed against recombinant AcrV-His protein could be protected from the toxic effect and showed only weak morphological changes. AcrV, which belongs to the type III secretion proteins is a determinative factor involved in virulence mechanisms of A. salmonicida, and is expected to provide new insights into basic mechanisms of pathogenicity of bacterial species. The components of the type III secretion system of A. salmonicida may be used as antigens for the development of sub-unit vaccines against infection of fish by A. salmonicida.

In one embodiment, the invention comprises an isolated 5.7 kb nucleic acid segment (SEQ ID NO:10) containing the type III secretion genes of A. salmonicida. In another embodiment, the invention comprises a nucleic acid segment that encodes protein having the amino acid sequence of SEQ ID NOS:1, 2, 3, 4, 5, 6, 7, 8, and 9, including variants that retain either biological activity or immunogenicity or both. Due to the degeneracy of the genetic code and the possible presence of flanking nucleic acid fragments outside of the coding regions, it will be understood that many different nucleic acid sequences may encode the amino acid sequence of SEQ ID NO NOS:1, 2, 3, 4, 5, 6, 7, 8, or 9, and variants, and that all such sequences would be encompassed within the scope of the present invention.

In a further embodiment, the invention relates to the use of AcrV as an immunogen, and to the use of AcrV in a recombinant or traditional vaccine to reduce the incidence of infection by A. salmonicida.

In another embodiment, the invention provides a means of diagnosing A. salmonicida, or other bacteria found to contain AcrV homologues, by the detection of the AcrV protein or the homologous proteins.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a genetic map of the type III secretion genes found in A. salmonicida. Boxes with arrowheads indicate open reading frames (ORFs). The size of the different genes (in kilobases) is shown by the scale bar. A restriction map containing restriction enzymes SacI, PstI, NotI, BamHI, and SalI is shown. Abbreviation used: acr, Aeromonas calcium response.

FIG. 2 is a segregation curve of A. salmonicida JF2267. An A. salmonicida JF2267 LB-culture was first incubated 2½ hrs at 19° C. and then at 22° C. for 7 hrs. Colony-blotting was performed to analyze the LB-culture at 10 different time points for positive, respectively negative colonies.

FIG. 3 shows a pulsed-field gel electrophoresis of A. salmonicida strain JF2267, and strain JF2397. (Lane 1) JF2267, undigested. (Lane 2) JF2397, undigested. (Lane 3) JF2267 digested with NotI. (Lane 4) JF2397 digested with NotI. (Lane 5) Low Range PFG Marker (New England Biolabs).

FIG. 4 shows infection of fish cells with A. salmonicida ATCC 33658^(T), JF2267, and JF2397. RTG-2 cells infected with JF2267 (A), ATCC 33658^(T) (B), JF2397 (C), and pure PBS (D). RTG-2 cells infected with JF2267 and monospecific polyclonal antibodies against AcrV were protected (E), whereas RTG-2 cells infected with JF2267 and anti-AcrV preserum (F) were not. Pictures were taken 24 hrs after infection, respectively 21 hrs after the protection assay under a phase contrast microscope.

FIG. 5 shows low Ca²⁺ response induced AcrV expression in A. salmonicida JF2267. The picture shows an immunoblot reacted with specific rabbit anti-AcrV antiserum. Strains ATCC33658^(T) (lane 2), JF2267 (lane 3) and JF2397 (lane 4) were grown in Ca²⁺ depleted medium, harvested by centrifugation and analyzed on 15% SDS PAGE followed by immunoblotting. Lane 1 contains purified recombinant AcrV-His protein as a control.

DETAILED DESCRIPTION

A 5.7 kb segment containing type III secretion genes of A. salmonicida that were cloned and sequenced correspond to the per locus (Pseudomonas calcium response) of Pseudomonas aeruginosa (Frank, 1997; Yahr et al., 1997b) and the virA operon and genes of the following operon of Yersinia enterocolitica (Cheng and Schneewind, 2000; Iriarte and Cornelis, 1999; Plano et al., 1991; Skrzypek and Straley, 1993; Motin et al., 1994; Price and Straley, 1989) and other Gram-negative animal and plant pathogens (Fenselau et al., 1992; Gough et al., 1992; Michiels and Cornelis, 1991). The most conserved gene at this locus was revealed to be the acrD gene encoding the AcrD protein, which showed 82% identical aa to the transmembrane spanning core proteins LcrD of the injectisome of the Y. enterocolitica type III secretion apparatus and PcrD of the injectisome of the P. aeruginosa type III secretion apparatus (Yahr et al., 1997b; Plano et al., 1991). Due to this high similarity, we conclude AcrD to have the analogous functions in the injectisome of the A. salmonicida type III secretion pathway.

The least conserved protein encoded on the cloned and analyzed segment is AcrV, which shows only 35% identical aa to PcrV of P. aeruginosa and 37% identity to LcrV of Y. enterocolitica. The main role of LcrV and PcrV, and accordingly also of AcrV, is assumed to be involved in sensing the bacterium-host interactions (Sawa et al., 1999; Bergman et al., 1991). We therefore interpret the significantly higher dissimilarity between AcrV and LcrV or PcrV, compared to the other gene products of the type III secretion locus (Table 3), to be due to the host specificity which seems to be determined by AcrV, LcrV or PcrV.

Our analyses revealed the A. salmonicida type III secretion genes to be located on a plasmid of 84 kb. The plasmid was shown to be lost very easily in standard growth media, in particular after a slight raise in growth temperature. Concomitant to the loss of the type III genes in A. salmonicida, we detected the loss in virulence of the strain as measured by the infection of RTG-2 fish cell cultures, as well as the loss of production of ADP-ribosylating toxin aexT in supernatants and bacterial cell pellets of low Ca²⁺ response induced A. salmonicida cultures. It is also noted that AexT biosynthesis induced by contact of A. salmonicida with RTG-2 fish cells disappeared in those strains or subcultures that had lost the type III secretion genes. Expression of the aexT gene must therefore be regulated by a mechanism which is dependent on type III secretion genes. In this context it must be noted that several genes of the type III secretion pathway of Yersinia spp., in particular LcrV, are down regulated and secretion and production of effector proteins is completely blocked in the presence of millimolar amounts of Ca²⁺ (Forsberg et al., 1987). It also became apparent from tissue culture infection models that the absence of Ca²⁺ in vitro mimics a yet undefined signal that is received by Yersinia species when they are adherent to eukaryotic cells and that induce both type III secretion genes and effector molecules such as YopE and Yops (Cornelis, 1998).

The dependence of aexT expression on type III secretion mechanism was also indicated by the presence of a consensus sequence upstream the aexT toxin gene in A. salmonicida, which shows full homology to the binding site of a transcriptional activator, known in P. aeruginosa as ExsA, which is involved in type III dependent gene expression (Frank, 1997). The expression of aexT in A. salmonicida is thus dependent on a functional type III secretion mechanism. The lack of production of AexT as detected in the type strain of A. salmonicida ATCC33658^(T) as well as in the strain JF2397 which was derived from an originally virulent A. salmonicida strain, JF2267, in spite of the presence of a functional aexT gene, must therefore be due to the loss of the type III secretion pathway.

The AcrV protein of the novel type III secretion pathway of A. salmonicida plays an important role in pathogenesis by its role as a sensor and regulator of the system, as shown in other type III secretion systems. An important role in the secretion-related regulatory role in the low Ca²⁺ response of Y. pestis is attributed to LcrV, which is localized to the bacterial surface and required for targeting of Yops of Y. pestis (Fields and Straley, 1999; Nilles et al., 1997). In addition, it was postulated that LcrV is also secreted by a special pathway which results its localization in the cytosol of infected cells but not the surrounding medium (Fields and Straley, 1999). Using a tissue cell model, it was shown that antiserum directed against LcrV prevented Y. pestis from injecting the Yop effector molecules into the host cells (Pettersson et al., 1999; Hueck, 1998). Active immunization of mice with recombinant LcrV antigen efficiently protected mice against challenge with Y. pestis (Leary et al., 1995). Our results showed that antibodies directed against recombinant AcrV, the analogous protein to LcrV, protected fish RTG-2 cells from damage caused by virulent A. salmonicida strain JF2267 and demonstrated that the AcrV plays an important role in type III secretion pathway mediated virulence of A. salmonicida.

The newly found type III secretion pathway plays a central role in pathogenicity of A. salmonicida via the secretion and direct injection of the ADP-ribosylating toxin AexT into the target cells. Loss of the type III secretion pathway, which is frequently observed, is due to the instability of a kb plasmid under culture conditions. Furthermore, loss of type III secretion genes such as acrD and acrV abolished expression of the aexT gene, and led to loss of virulence of A. salmonicida. As shown, surface exposed gene products of this type III secretion pathway, in particular AcrV, are potent candidates for new vaccines for the immune prophylaxis of fish against furunculosis.

The invention is further described by way of the following examples and results, which are not to be considered as limiting the scope of the invention. It will be appreciated by those skilled in the art, in light of this disclosure, that many changes can be made in the specific embodiments disclosed without departing from the scope of the invention.

EXAMPLES AND RESULTS Materials and Methods

Bacterial Strains, Growth Conditions and Cloning Vectors:

A. salmonicida strains are listed in Table 1. A. salmonicida type strain ATCC 33658^(T) was purchased from the American Type Culture Collection. A. salmonicida strain JF2267 was freshly isolated from an arctic char (Savelinus alpinus) showing typical symptoms of furunculoses. A. salmonicida strain JF2397 was derived from strain JF2267 by repeated single colony isolations after each of nine passages propagated on LB agar medium at 22° C. for two days each passage. A. salmonicida strains were routinely cultured on blood agar plates (Trypticase soy agar supplemented with 0.1% CaCl₂ and 5% sheep blood) at 19° C. unless otherwise mentioned.

TABLE 1 A. salmonicida used in this study and presence of acrD Strain origin acrD^(a)) ATCC33658 American Type Culture Collection, Type strain − JF2267 Char (Savelinus alpinus), Switzerland + JF2397 Laboratory strain, derivative of JF2267 − CC-23 Salmon, Norway + CC-24 Salmon, Norway +/−^(b)) CC-27 Salmon, Norway + CC-29 Salmon, Scotland, UK + CC-30 Salmon, Canada + CC-34 Salmon, Canada + MT 44 Spontaneous non virulent mutant − CC-63 Salmon, Canada + CC-72 Salmon, Canada + ^(a))As determined by Southern blot hybridization. ^(b))Very weak hybridization signal indicating that only a minor part of the population of the culture contains the acrD gene.

Liquid cultures of A. salmonicida were made by inoculation of Tripticase soy broth (TSB) (2.75 g/100 ml Tripticase soy broth without Dextrose (BBL® 11774, Becton Dickinson AG, Basle, Switzerland), 0.1% Glycerol, 0.1 M L-Glutamic acid pH 7.3) with fresh culture from solid medium and subsequent growth for 18 h at 19° C. For growth in Ca²⁺-restricted medium, TSB was supplemented with 10 mM Nitrilotriacetic acid (Titriplex I, Merck 1.08416, Darmstadt, Germany).

For cloning and expression of cloned genes, Escherichia coli strains. XL1-blue (recA1 endA1, gyrA96 thi-1 hsdR17supE44 relA1 lac [F′ proAB lacI^(q)ZΔM15 Tn10 (Tet^(T))] (Bullock et al., 1987), and BL21 (DE3) (F′dcm ompT hsdS(r_(B)-m_(B)-) gal λDE3)) (Studier et al., 1990) respectively, were used. Plasmid pBluescriptII-SK⁻ (Stratagene, La Jolla, Calif., USA) was used as basic cloning vector. For the construction of genes encoding poly-Histidine fusion proteins and their expression, plasmid pETHIS-1, a T7 promoter based expression vector (Schaller et al., 1999) was used. E. coli strains were grown at 37° C. in Luria-Bertani broth (LB) supplemented when necessary with ampicillin (50 μg/ml) for selection and maintenance of recombinant plasmids. When blue-white selection with pBluescriptIISK⁻ was performed, 125 μM X-Gal medium was supplemented with 5-bromo-4-chloro-3-indolyl-β-D-thiogalacto-pyranoside.

Preparation of Genomic DNA, Cloning and Sequencing Procedures:

Genomic DNA of A. salmonicida was extracted by the guanidium hydrochloride method (Pitcher et al., 1989). A partial gene library of, A. salmonicida JF2267 was constructed by cloning agarose gel purified SacI-SalI digested fragments of 4 to 6 kb size into vector pBluescriptII-SK⁻ using standard procedures (Ausubel et al., 1999). Recombinant plasmids were screened by colony blot (Ausubel et al., 1999) using digoxigenin (DIG)-labeled DNA probes as described previously (Braun et al., 1999). Plasmids from A. salmonicida were purified using the method of Birnboim and Doly (Birnboim and Doly, 1979).

To construct a genomic library from A. salmonicida JF2267, 0.1 μg of DNA partially digested with Sau3a was ligated to ZapExpress BamHI prepared arms (Pharmacia, Uppsala, Sweden) and packed into phage Lambda. Two-hundred μl of freshly grown XL1-blue MRF′ cells (Pharmacia) resuspended in 10 mM MgSO₄ were infected with the packed phages during 15 min at 37° C. Three ml of preheated (50° C.) Top Agarose (LB-broth containing 0.7% Agarose) supplemented with IPTG and X-Gal for blue/white selection were added and the mixture was poured onto an LB-Agar plate. Plates were incubated overnight at 37° C. and then used for screening of plaques. Positive plaques were cut out and stored overnight at 4° C. in 0.5 ml SM-buffer (100 mM NaCl, 8 mM MgSO₄, 50 mM Tris, pH 7.5, and 0.01% gelatine) containing 20 μl chloroform. 20 ml overnight cultures of XL1-blue MRF′ grown in LB supplemented with 0.2% maltose and 10 mM MgSO₄ and 20 ml XLOLR cells (Pharmacia) grown in LB media were centrifuged for 5 min at 4,000 rpm and resuspended in 10 mM MgSO₄ to a final OD₆₀₀=1. Two-hundred μl the XL1-blue MRF′ cells were added to 250 μl of the SM-buffer containing the positive phages and 1 μl (10⁷ pfu) ExAssist™ helper phage. This mixture was incubated 15 min at 37° C. and 3 ml LB-broth were added and shaken another 3 hrs at 37° C. The cultures were then heated for 15 min at 70° C., centrifuged during 15 min at 5,700 rpm, 4° C., and the supernatant containing the pBK-CMV phagemid filamentous phage was decanted into fresh tubes. Two-hundred μl XLOLR cells were mixed with 100 μl supernatant and incubated for 15 min at 37° C., 300 μl LB-broth were added and the culture was incubated for another one hr at 37° C. Two-hundred μl of this culture were plated on LB-plates containing 50 mg/l kanamycin overnight at 37° C. Colonies were picked and mini-preps (using the QIAprep Spin Miniprep kit, Qiagen AG, Basle, Switzerland) performed for plasmid purification.

For sequencing, subclones of sequential DNA segments were generated with a double-stranded nested deletion kit (Pharmacia LKB, Biotechnology AB, Uppsala, Sweden). Sequencing was done with the dRhodamine Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, Calif.) according to the manufacturer's protocol using either T3 and T7 primers flanking the cloned inserts in pBluescriptII-SK⁻ or customer-synthesized internal primers. All sequences were determined on both strands. Reaction products were analyzed on an ABI Prism 310 genetic analyzer (Applied Biosystems).

Sequence Data Analyses:

Sequence alignment and editing were performed by using the software Sequencer (Gene Codes Corporation, Ann Arbor, Mich., USA). Comparisons of DNA sequences and their deduced amino acid sequences with EMBL/GenBank and NBRF databases were performed using the programs BLASTN, BLASTX and BLASTP (Altschul et al., 1990). Potentially antigenic segments of AcrV were determined using the software ProtScale (Bairoch et al., 1995) and the software Coils output (Lupas et al., 1991). The molecular masses of the protein and its theoretical isoelectric pH (pI) were calculated by using ProtParam tool (Gill and von Hippel, 1989). Transmembrane prediction of the protein were made by using Tmpred (Hofmann and Stoffel, 1993).

PCR Amplifications and Preparations of DIG-labeled Gene Probes:

Template DNA was produced either by extraction of genomic DNA or by preparation of lysates from bacterial colonies. Lysates were obtained by resuspending five colonies of the corresponding bacterial cultures in 200 μl lysis buffer (100 mM Tris-HCl, pH 8.5, 0.05% Tween 20 (Merck), 0.24 mg/ml proteinase K (Roche Diagnostics, Rotkreuz, Switzerland) dissolved in pyrogen-free water, filtered through a 0.22 μm low protein binding membrane filter) followed by subsequent incubation for 60 min at 60° C. and 15 min at 97° C. Lysates were then cooled on ice and used as PCR templates.

PCR amplifications were performed with either a PE9600 or PE2400 automated thermocycler with MicroAmp tubes (Applied Biosystems). The reaction was carried out in a 50 μl reaction mix (10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl₂, 50 mM KCl, 0.005% Tween 20, 0.005% NP-40 detergent, 170 μM of each deoxinucleoside triphosphate (dATP, dCTP, dGTP, dTTP), 0.25 μM of each primer, 2.5 units Taq DNA polymerase (Roche Diagnostics)), and 100 ng of template DNA or 5 μl lysate. For the production of DIG-labeled probes, PCR mixtures were supplemented with 40 μM digoxigenin-11-dUTP (Roche Diagnostics). PCR conditions were as follows: 3 min at 94° C. followed by 35 cycles of 30 s at 94° C., 1 min at the corresponding annealing temperature (Table 2), and 30 s at 72° C. In addition, an extension step of 7 min at 72° C. was added at the end of the last cycle in order to ensure fall length synthesis of the fragments.

TABLE 2 Oligonucleotide primers Residue Nos. of SEQ ID Annealing Name Sequence^(a) 5′ to 3′ NO: 10^(b) temp. ° C. AslcrD-L^(c) GCCCGTTTTGCCTATCAA 1159-1176 60 (SEQ ID NO: 16) AslcrD-R^(c) GCGCCGATATCGGTACCC 2028-2011 60 (SEQ ID NO: 17) AcrV-L^(c) TTCGTCGGCTGGCTTGATGT 4144-4163 58 (SEQ ID NO: 18) AcrV-R^(c) GAACTCGCCCCCTTCCATAA 4734-4715 58 (SEQ ID NO: 19) AsacrVt-L^(d) gggaattcGATGAGCACAATCCCTGACTAC 4104-4125 57 (SEQ ID NO: 11) AsacrVt-R^(d) atgcggccgcAAATTGCGCCAAGAATGTCG 5188-5169 57 (SEQ ID NO: 12) AsacrVN′-R^(d) tcgcggccgcACCCTTTACGCTGATTGTC 4555-4537 57 (SEQ. ID NO: 13) AsacrVC′-L^(d) cggaattcGTTGCGGGATGAGCTGGCAG 4554-4573 57 (SEQ. ID NO: 14) AsacrVC′-R^(d) tcgcggccgcACTCGGCTTCTATGCCACTC 4987-4968 57 (SEQ. ID NO: 15) ^(a)Lowercase letters indicate nucleotides added to create restriction enzyme recognition sites (underlined) for cloning. ^(b)Based on nucleotide sequence of A. salmonicida JF2267 ^(c)Primer used for gene probe preparation ^(d)Primer used for amplification of gene acrV, acrV-N, and acrV-C respectively Curing of Type III Secretion Genes from A. Salmonicida:

In order to study the segregation of the type III secretion genes in A. salmonicida strain JF2267, the strain was inoculated in LB-broth at a density of A₆₀₀=0.08 and incubated 2½ hrs at 19° C. Then the culture was split in two. One part was kept for continued growth at 19° C., while the other part was incubated at 22° C. Samples were taken at different time points from both cultures and spread on LB-agar medium. The plates were then incubated at 19° C. for 24 hrs. Subsequently, colony blot hybridizations were performed using gene probes to determine the loss of specific genes.

Pulsed-field Gel Electrophoresis (PFGE):

The bacterial strains A. salmonicida JF2267 and JF2397 were grown on LB agar for one day at room temperature. Then bacterial suspensions in 10 mM Tris, 10 mM EDTA, pH 8.0, sterile, were prepared to a final OD₆₀₀ of 5. Three-hundred μl of 1.5% Sea Kem gold agarose (FMC Bioproducts, Maine, USA) in 100 mM Tris, 100 mM EDTA, pH 8.0, was added to 300 μl of bacterial cell suspension. Plugs were immediately poured in sterile moulds and kept on ice until hardened. The plugs were then incubated at 50° C. overnight in sterile 1.5 ml 0.5 M EDTA, 1% N-lauroylsarcosin, 2 mg/ml proteinase K (Roche Diagnostics), pH 8.0, by shaking. The next day, the plugs were thoroughly washed 5 times over the whole day at room temperature in sterile TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and stored in sterile 0.5 M EDTA, pH 8.0, at 4° C. until further use. To digest the plugs they were first incubated in 4× Buffer H (Roche Diagnostics) for 10 min at 22° C. Then the plugs were incubated at 37° C. by shaking for 7½ hrs in 2× Buffer H containing 40 U of NotI (Roche Diagnostics). They were then placed into the slots of a 1% Sea Kem gold agarose gel in 0.5×TBE and sealed with 1% Sea Kem gold agarose. The gel was then equilibrated in 0.5×TBE at 12° C. using an Electrophoresis CHEF-DR® III system (BioRad Laboratories, Hercules, Calif., USA). To separate NotI DNA fragments, the field was 6V/cm, having an angle of 12°, starting with 1 s and ending with 12 s. The duration of the PFGE was 14 hrs and it was performed at 12° C. The gel was stained 30 min at room temperature in water containing 0.5 μg/ml ethidium bromide, washed two times with water and analyzed under a UV-light. Additionally, the gel was further used for Southern-blotting.

Southern-blot Analyses:

Southern-blotting was done by alkaline transfer onto positively charged nylon membranes (Roche Diagnostics) with an LKB 2016 VacuGene vacuum blotting pump (Pharmacia LKB). To depurinate the agarose gels they were incubated for 10 min in 0.25 M HCl, and subsequent transfer was performed with 0.4 M NaOH for 1½ hrs. After blotting, membranes were baked for 30 min at 80° C. under vacuum. After at least one hr of prehybridization, hybridization was carried out in 5×SSC (1×SSC in 0.15 M NaCl plus 0.015 M sodium citrate)-1% blocking reagent (Roche Diagnostics)-0.1% N-lauroylsarcosine sodium salt-0.02% sodium dodecyl sulphate (SDS) at 68° C. overnight, using DIG-labeled DNA as probe. Membranes were washed under nonstringent conditions twice for 5 min each with 50 ml of 2×SSC-0.1% SDS per 100 cm² at 22° C., followed by medium-high-stringency washing twice for 15 min each with 50 ml of 0.2×SSC-0.1% SDS per 100 cm² at 68° C. The membranes were then processed with phosphatase-labeled anti-DIG antibody (Roche Diagnostics) according to the manufacturer's protocol. Signals were produced with chemiluminescent substrate (CSPD, Roche Diagnostics).

Pulsed-field gels were treated for Southern-blotting by using the same solutions as described above. To depurinate the agarose gels efficiently, they were incubated for 20 min in 0.25 M HCl, and then equilibrated for 20 min in 0.4 M NaOH. Transfer was performed for 3 hrs and the gels were treated as described above.

Expression and Purification of His-tailed Fusion Protein AcrV:

Oligonucleotide primers used to amplify the whole acrV gene are given in Table 2. The PCR reactions were carried out as described above with the exception of using Pwo DNA polymerase (Expand Long Template PCR System kit, Roche Diagnostics) instead of Taq DNA polymerase and genomic DNA of A. salmonicida JF2267. The PCR products were purified by using the High Pure™ PCR Product Purification Kit (Roche Diagnostics) as described by the manufacturer's protocol. Then the acrV PCR product was cloned into pGEM-T vector (Promega, Madison, Wis. USA), having 3′-T overhangs at the insertion sites, as described in the manufacturer's protocol and transformed into E. coli strains XL-1 Blue. The resulting plasmid was designated pJFFIVB873. The cloning of the PCR products into pGEM-T vector was used to provide efficient restriction of the subcloned fragments. Plasmid pJFFIVB873 was then digested with EcoRI and NotI, and the DNA fragment was inserted into the T7-promoter-based expression vector pETHIS-1 (Schaller et al., 1999). The resulting plasmid, pJFFETHISacrV4 was purified and controlled by DNA sequencing to assure the fusions with the vector's poly-His codons and then transformed into Escherichia coli BL21 (DE3) cells (Novagen) for expression. Expression was induced by addition of 1 mM IPTG to cultures and incubation continued for another 3 h. The cells were sedimented by centrifugation at 3000×g for 10 min, resuspended in 5 ml PN buffer (50 mM NaH₂PO₄, pH 8.0, 300 mM NaCl), sonicated with a microtip for 4 min with the power output control at 1 and a duty cycle of 50% (1 s pulses) in a Branson Sonifier 250 (Branson Ultrasonics, Danbury, Conn., USA). Then guanidine hydrochloride was added to a final concentration of 6 M and was incubated overnight at 4° C. on a shaker. The mixture was loaded onto a prewashed 2.5 ml bed volume Ni²⁺ chelation chromatography column (Qiagen) and washed once more with 30 ml PNG buffer (50 mM NaH₂PO₄, pH 8.0, 300 mM NaCl, 6 M guanidine hydrochloride). Step elutions of the proteins were performed by adding 10 ml PNG buffer at each different pH (7.0, 6.0, 5.5, 5.0, and 4.5) and fractions of 1 ml were collected. The fractions were dialyzed and analyzed on 15% PAGE. The purified fusion proteins were eluted at pH 4.5.

Production of Monospecific Rabbit Anti-AcrV Antibodies and Immunoblot Analyses:

Monospecific, polyclonal antibodies directed against AcrV were obtained by immunizing rabbits subcutaneous with 80 μg of recombinant polyhistidine-tailed AcrV protein in 200 μl PN buffer and 150 μl NaCl (0.85%) mixed with 350 μl Freund's complete adjuvant (Difco Laboratories, Detroit, Mich., USA) followed by a booster immunization with the same amount of protein in Freund's incomplete adjuvant (Difco)3 weeks later. The animals were bled 22 d after the booster immunization according to standard protocols (Harlow and Lane, 1988).

Infection of Fish Cell Cultures with A. Salmonicida:

Rainbow trout (Oncorhynchus mykiss) gonad cells (RTG-2, ATCC CCL-55) were grown in 75 cm² tissue culture flasks (Techno plastic products AG, Trasadingen, Switzerland) at 22° C. in minimum essential medium (GibcoBRL Life Technologies, Basel, Switzerland) supplemented with 2 mM L-glutamine (GibcoBRL), 1Xnon-essential amino acids (GibcoBRL), 3 g/l sodium bicarbonate and 10% foetal bovine serum. Three days before infection the cells were trypsinized and 4 mio cells were seeded into a 25 cm² tissue culture flask. Monolayered RTG-2 cells were infected with A. salmonicida cells resuspended in phosphate buffered saline (PBS) pH 7.4 at a multiplicity of infection of 20:1 or 2:1 (bacteria/fish cells). As a control also 100 μl of pure PBS pH 7.4 were added to cultured fish cells. After 24 hrs of infection at 15° C. the fish cells were photographed under a green filtered phase contrast microscope (Aixovert 100, Zeiss, Jena, Germany). To detach the cultured cells from the flask, the flask was shaken by hand. The suspended cells were centrifuged for 5 min at 4,000 rpm. Lysis of the fish cells was performed in 100 μl distilled water with two subsequent freeze thawing steps and verified by microscopy. The lysed fish cells were used for further analyzes on Western-blots.

Protection Assay Using Rabbit Antiserum AcrV:

RTG-2 fish cells were grown as described above. Two days before infection 20 million of trypsinized RTG-2 fish cells were seeded into 24 well culture plates (1.9 cm²) (Techno plastic products AG, Trasadingen, Switzerland). Rabbit antiserum directed against AcrV as well as control preserum were decomplemented for 30 min at 56° C. A fresh culture of A. salmonicida (at end exponential growth phase) was washed and resuspended in PBS pH 7.4 and mixed with either preserum or anti AcrV antiserum at a ratio of 1:1, 1:10, 1:100, 1:1000 or 1:10,000. Bacteria were incubated with the serum at 18° C. for 30 min. The opsonized bacteria were added to the fish cells in a ratio of 20:1 or 2:1 (bacteria/fish cells). After 21 hrs of infection at 15° C. the fish cells were photographed as described before and inspected for morphological changes.

SDS-PAGE and Immunoblot Analysis:

Proteins were separated by polyacrylamide gel electrophoresis (SDS-PAGE) as described by Laemmli (Laemmli, 1970) using 15% or 10% polyacrid gels and transferred to a nitrocellulose membrane (BioRad Laboratories). For immunoblotting, Western-blots were blocked with 1% milk buffer for at least one hour and then incubated with the rabbit antiserum AcrV (1:2000) or with the rabbit preserum (1:1000) in milk buffer overnight at 4° C. The membranes were then washed thoroughly with water before phosphatase-labelled conjugate (Goat anti-Rabbit IgG (H+ L) [cat. no. 075-1506], Kirkegaard & Perry, Gaithersburg, Md., USA) diluted 1:2000 in milk buffer was added. The reaction was visualized 90 min later by incubation with BCIP-NBT (Ausubel et al., 1999).

EXAMPLES/RESULTS Cloning and Sequence Analysis of the virA Locus of a Type III Pathway of A. salmonicida

Analysis of A. salmonicida strain JF2267 with an array of broad range probes for detection of type III secretion pathways revealed a strong signal with the lcrD subset of the probes, indicating the presence of a new type III secretion pathway. Subsequent Southern-blot analyses showed a 4.8 kb fragment of SacI-SalI digested genomic DNA of strain JF2267 reacting with the lcrD probe. This fragment was cloned on vector pBluescriptII-SK⁻ leading to plasmid pJFFIVB638 which was subsequently sequenced. DNA sequence analyses revealed the presence of eight open reading frames (ORF) (FIG. 1) which showed strong similarity to the genes encoded on the virA operon of the type III secretion pathway of Yersinia pestis and Pseudomonas aeruginosa. In analogy to the Y. pestis genes, we named them acr1, acr2, acr3, acr4, and acrD (Aeromonas calcium response (FIG. 1)). They are located on a single operon followed by a transcription termination signal similar to the virA operon of Y. pestis, Y. enterocolitica and Pseudomonas aeruginosa (Boland et al., 1996; Iriarte and Cornelis, 1999; Plano et al., 1991; Cornelis, 1998; Yahr et al., 1997a). The similarities of the genes acr1, acr2, acr3, acr4 and acrD with the analogues in Y. enteroclitica and in P. aeruginosa are given in Table 2. Downstream lcrD we identified a locus with a canonical promoter sequence followed by further genes named acrR, acrG, and acrV on a separate operon (FIG. 1) according to the corresponding genes in Y. pestis (Table 3) (Barve and Straley, 1990; Skrzypek and Straley, 1993; Nilles et al., 1998). The ORF of the putative acrV gene seemed to be incomplete on the 4.8 kb SacI-SalI fragment of pJFFIVB638, and represented only the 5′-half of the gene. The remaining part of acrV and part of acrH located downstream of acrV were cloned separately from the λ phage gene library of A. salmonicida as an overlapping clone which was obtained by screening the gene library using a gene probe for the 5′-half of acrV which was produced by PCR with primers AcrV-L and AcrV-R (Table 2). The resulting plasmid based on vector pBK-CMV was designated pJFFIVB832. From this plasmid, a 0.9 kb SalI fragment containing the 3′ end of acrV and part of the downstream gene acrH was subcloned on pBluescriptII-SK and designated pJFFIVB828.

TABLE 3 A. salmonicida type III proteins compared to analogues in P. aeruginosa and in V. entercolitica Protein in Analogue in Similarity/ Genbank Analogue in Similarity/ Genbank A. salmonicida P. aeruginosa identity^(a) Access. Nr. Y. enterocolitica identity^(a) Access. Nr. Proposed function Acr1 Pcr1 80/60 AF019150 TyeA 83/69 AF102990 part of the translocation-control apparatus, required for selective translocation of Yops Acr2 Pcr2 63/44 AF019150 SycN 77/62 AF102990 chaperone for YopN Acr3 Pcr3 62/47 AF019150 YscX 69/54 AF102990 part of the type III secretion apparatus, secretion of Yop Acr4 Pcr4 66/55 AF019150 YscY 64/52 AP102990 part of the type III secretion apparatus, secretion of Yop AcrD PcrD 90/82 AF019150 LcrD 90/82 X87771 inner membrane spanning protein of type III secretion AcrR PcrR 68/58 AF019150 LcrR 71/58 AF102990 AcrG PcrG 63/46 AF010149 LcrG 64/42 AF102990 regulation of low calcium response AcrV PcrV 50/35 AF010149 LcrV 53/37 X96797 regulation of low calcium response, sensor suppression of TNFá and Interferon ã, protective antigen AcrH PcrH 78/65 AF010149 LcrH (SycD) 79/58 AF102990 regulation of low calcium response, chaperon for YopD, secretion ^(a)Given as % of similar/identical amino acids Instability of the Genes Belonging to the Type III Pathway in A. Salmonicida:

When we analyzed the different A. salmonicida strains with a specific probe for acrD, we discovered by using Southern blot hybridization that the acrD gene was present only in strain JF2267 but not in the derivative strain JF2397 which had undergone nine passages of subsequent single colony cloning isolation. Additionally, the type strain of A. salmonicida, ATCC33658^(T), did not show a signal with the acrD probe. However, several A. salmonicida strains that were freshly isolated from salmon and trout with furunculoses did contain acrD (Table 1). These results indicate that the type III secretion pathway of A. salmonicida may be lost easily. In order to get an estimate on the loss of the type III secretion genes, we have analyzed the kinetics of disappearance of acrD after a shift of growth temperature of strain JF2267 from 19° C. to 22° C. Colony hybridization with the acrV probe revealed that in a fresh culture of strain JF2267, the acrD gene was present in all cells grown at 19° C. After the shift to 22° C., acrD was still present for further 5½ hrs, following which it was lost very rapidly within less than 1 hr (FIG. 2). Taking into account the generation time of 2 h for A. salmonicida under the given growth conditions, the acrD gene was lost within two generations. To analyze the loss of acrD further, undigested and NotI digested genomic DNA of A. salmonicida strain JF2267 and of the acrD deficient derivative strain JF2397 were submitted to pulse field gel electrophoresis (PFGE) and subsequent Southern blot hybridization with the acrD probe. PFGE analyses of total undigested DNA revealed the presence of two large plasmids in strain JF2267 while in strain JF2397 only one of the two plasmids was seen (FIG. 3). Digestion of the total DNA from these two strains with the rarely cutting enzyme NotI revealed the lack of a 84 kb band in strain JF2397 compared to JF2267 as the sole detectable difference (FIG. 3). Southern-blot hybridization of the DNA on this gels with the acrD probe confirmed the larger plasmid and the 84 kb NotI fragment of strain JF2267 to contain acrD gene. Neither the remaining large plasmid in JF2397 nor any of its NotI fragments hybridized with the AcrV probe. This indicates that the type III secretion genes, or at least the virA operon thereof, are located on a large plasmid in the size range of 84 kb.

Presence of acrD in A. salmonicida Strains:

In order to assess the presence of the acrD gene in various A. salmonicida strains, DNA samples extracted from A. salmonicida Type strain ATCC 33658 and various field strains isolated from salmon or char were digested with restriction enzymes SalI and SacI, separated by 0.7% agarose gel electrophoresis, blotted onto nylon membranes and hybridized with the acrD gene probe. The Southern blot revealed the presence of the acrD gene on a 4.8 kb fragment in all strains except in the type strain ATCC 33658, the laboratory strain JF2397 which was used for the type III secretion genes, and A. salmonicida strain MT44 known to be a virulent for trout. One field strain, # 24, showed a very weak hybridization signal indicating that the culture contains acrD only in a minor population of the cells (Table 1).

Infection of RTG-2 Fish Cells and Protection of Cell Damage with Anti-AcrV Antiserum:

Freshly cultured A. salmonicida strain JF2267 was used to infect RTG-2 cells. After 24 hrs of incubation the fish cells were rounded up and also detached from the plastic support (FIG. 4A). In contrast cells infected with A. salmonicida type strain ATCC 33658^(T) or strain JF2397 (FIGS. 4B and C), both known to be devoid of acrD and acrV, showed no morphological changes at all in spite of a massive multiplication of the bacteria in the cultures. RTG-2 fish cells which were incubated with PBS buffer as control showed no morphological changes like the cells infected with the acrD and acrV deficient strains JF2397 or ATCC 33658^(T) (FIG. 4D).

In order to study further the role of the newly detected type III secretion pathway in virulence of A. salmonicida, we incubated strain JF 2267 with monospecific polyclonal anti-AcrV antibodies prior to infection of RTG-2 fish cell cultures. When RTG-2 fish cells were infected with strain JF2267 that was incubated with rabbit anti-AcrV antibodies diluted 1:1 or 1:10, the characteristic morphological changes of the cells were reduced, significantly affecting only 20% of the cells or less (FIG. 4E) compared to the infection with non-treated strain JF 2267 (FIG. 4A) or to the infection with JF 2267 that was pretreated with serum from the same rabbit taken before immunization (FIG. 4F). Titration of the anti-AcrV serum showed that protection of about 50% of the RTG-2 cells could still be reached with a serum dilution of 1:100, while further dilutions had no visible effect in protection.

Expression of AcrV in A. salmonicida:

The expression of AcrV in A. salmonicida strain JF2267 was assessed by immunoblots using AcrV-His antibodies. When A. salmonicida was grown under standard culture conditions in TSB medium, no AcrV protein could be detected from total cells nor from culture supernatant of strain JF 2267, nor in the control of strains JF2397 and ATCC33658^(T). However, when the cells are submitted to a low Ca²⁺ response by chelating free Ca⁺ ions in the growth medium by the addition of 10 mM NTA, we detected AcrV with anti-AcrV antibodies in the pellet of JF2267 as a protein of about 37 kDa (FIG. 5) but not in strains JF2397 and ATCC33658^(T), which are both devoid of the AcrV gene (FIG. 5). No AcrV protein could be detected in the supernatants of cultures from strains JF2267, JF2397 and ATCC33658^(T), grown in Ca²⁺ depleted medium.

When strain JF2267 was grown under standard culture conditions (containing free Ca²⁺ ions) and then put in contact with RTG-2 cells at a ratio 2:1 (bacteria:cells) for 30 minutes, the AcrV protein could be monitored on immunoblots reacting with anti-AcrV, similar to cultures from Ca²⁺ depleted medium.

Recombinant AcrV Vaccine Trial

Materials

Vaccine Formulations:

-   1. The AcrV vaccine was formulated using recombinant,     Histidine-tagged AcrV resuspended in 10 mM phosphate buffer, pH 7.0,     to 112.5 μg/mL. Four parts of this protein solution were mixed with     one part oil adjuvant for a final AcrV concentration of 90 μg/mL The     dose for testing was 0.1 mL, or 9 μg/fish. -   2. The commercial comparator vacciuc was serial 4-13 of the vaccine     MultiVacc4 (Bayotek International Ltd.). -   3. The placebo (control) vaccine consisted of phosphate buffered     saline (PBS) (10 mM phosphate, 150 mM NaCl, pH 7.2). -   4. All vaccines were maintained at 4° C. until use.

Methods

Trial Design:

Fish (rainbow trout Oncorhynchus mykiss) that have been determined to be pathogen free and are at least 15 g in size are held for at least one-week pre vaccination for acclimation purposes. During the acclimation period the fish are offered 1% body weight in salmonid fish food every day, however they are denied food 24 hours pre and post-vaccination.

At least 50 fish are vaccinated 0.1 mL of AcrV vaccine via intra-peritoneal (IP) injection, or 0.2 mL of the commercial vaccine MutiVacc4. At the same time a group of at least 50 fish from the same stock are mock vaccinated with 0.1 mL of PBS. Vaccinated fish are then held for a period of at least 350-degree days to allow specific immune response generation in an acclimation tank with a continuous flow of water at a temperature of 12-13° C. The fish are offered 1% body weight in salmonid fish food daily until 24 hours pre-challenge and post-challenge.

After at least 350-degree days post vaccination 50 fish per group were challenged by IP injection with a pre-determined concentration of virulent Aeromonas salmonicida. The dosage depends on the source of the fish and the water temperature (this is determined empirically immediately prior to challenge of test fish). The identical procedure is performed with the placebo vaccinated control fish. The fish are observed daily for mortality for 21 days post challenge and the cause of mortality assessed and examined to ensure that mortality is attributed to the challenge organism. After 24 hours post-challenge the fish are again offered 1% body weight in salmonid fish feed daily. Tanks are maintained with a continuous flow of water at a temperature of 12-13° C. For a challenge series to be considered satisfactory; all challenge groups must meet the following criteria:

-   1. At least 70% of the non-immunized controls must die within 21     days of challenge. -   2. A relative percent survival (RPS) of no less than 25% must be     achieved for the challenge disease before a vaccine is considered     even partially efficacious for this disease.     RPS[=1−(% mortality vaccinates/% mortality controls)]×100     Developed from: The Rules Governing Medicinal Products in the     European Union, Volume VII, Guidelines for the testing of veterinary     medicinal products. 1994. Specific Requirements for the Production     and Control of Live and Inactivated Vaccines Intended for Fish.     Section 3.2. Potency.     Results:

Group % Mortality RPS PBS 82 — AcrV 49 40 MultiVacc4 30 63 There was a strong challenge with 82% control mortalities.

REFERENCES

-   Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D.     J.: Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403     410. -   Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D.,     Seidman, J. G., Smith, J. A. and Struhl, K.: Current protocols in     molecular biology. John Wiley & Sons, Inc., New York, N.Y., 1999. -   Bairoch, A., Bucher, P. and Hofmann, K: The PROSITE database, its     status in 1995. Nucleic Acids Res. 24 (1995) 189 196. -   Barve, S. S. and Straley, S. C.: lcrR, a low-Ca²⁺ response locus     with dual Ca²⁺ dependent functions in Yersinia pestis. J. Bacteriol.     172 (1990) 4661 4671. -   Bergman, T., Hakansson, S., Forsberg, A., Norlander, L., Macellaro,     A., Backman, A., Bolin, I. and Wolf-Watz, H.: Analysis of the V     antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence     for a regulatory role of LcrH and LcrV. J. Bacteriol. 173 (1991)     1607 1616. -   Birnboim, H. C. and Doly, J.: A rapid alkaline extraction procedure     for screening recombinant plasmid DNA. Nucleic Acids Res. 7 (1979)     1513 1523. -   Boland, A, Sory, M. P., Iriarte, M., Kerbourch, C., Wattiau, P. and     Cornelis, G. R.: Status of YopM and YopN in the Yersinia Yop     virulon: YopM of Y. enterocolitica is internalized inside the     cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.     EMBO J. 15 (1996) 5191 5201. -   Braun, M., Kuhnert, P., Nicolet, J., Burnens, A. P. and Frey, J.:     Cloning and characterization of two bistructural S-layer-RTX     proteins from Campylobacter rectus. J. Bacteriol. 181 (1999) 2501     2506. -   Bullock, W. O., Fernandez, J. M. and Short, J. M.: XL1-Blue: A high     frequency efficiency plasmid transforming recA Escherichia coli     strain with beta-galactosidase selection. Biotechniques 5 (1987) 376     378. -   Cheng, L. W. and Schneewind, O.: Yersinia enterocolitica TyeA, an     intracellular regulator of the type III machinery, is required for     specific targeting of YopE, YopH, YopM, and YopN into the cytosol of     eukaryotic cells. J. Bacteriol. 182 (2000) 3183 3190. -   Chu, S., Cavaignac, S., Feutrier, J., Phipps, B. M., Kostrzynska,     M., Kay, W. W. and Trust, T. J.: Structure of the tetragonal surface     virulence array protein and gene of Aeromonas salmonicida. J. Biol.     Chem. 266 (1991) 15258 15265. -   Cornelis, G. R.: The Yersinia Yop virulon, a bacterial system to     subvert cells of the primary host defense. Folia Microbiol. (Praha)     43 (1998) 253 261. -   Ellis, A. E.: Immunization with bacterial antigens: furunculoses.     Dev. Biol. Stand. 90 (1997) 107-116. -   Fenselau, S., Balbo, I. and Bonas, U.: Determinants of pathogenicity     in Xanthomonas campestris pv. vesicatoria are related to proteins     involved in secretion in bacterial pathogens of animals. Mol. Plant     Microbe Interact. 5 (1992) 390 396. -   Fields, K. A. and Straley, S. C.: LcrV of Yersinia pestis enters     infected eukaryotic cells by a virulence plasmid-independent     mechanism. Infect. Immun. 67 (1999) 4801 4813. -   Forsberg, A., Bolin, I., Norlander, L. and Wolf-Watz, H.: Molecular     cloning and expression of calcium-regulated, plasmid-coded proteins     of Y. pseudotuberculosis. Microb. Pathog. 2 (1987) 123 137. -   Frank, D. W.: The exoenzyme S regulon of Pseudomonas aeruginosa.     Mol. Microbiol. 26 (1997) 621 629. -   Gill, S. C. and von Hippel, P. H.: Calculation of protein extinction     coefficients from amino acid sequence data [published erratum     appears in Anal Biochem 1990 September; 189(2):283]. Anal. Biochem.     182 (1989) 319 326. -   Gough, C. L., Genin, S., Zischek, C. and Boucher, C. A.: hrp genes     of Pseudomonas solanacearum are homologous to pathogenicity     determinants of animal pathogenic bacteria and are conserved among     plant pathogenic bacteria. Mol. Plant Microbe Interact. 5 (1992)     384389. -   Harlow, E. and Lane, D.: Antibodies. A laboratory manual. Cold     Spring Harbor Laboratory, 1988. -   Hirono, I. and Aoki, T.: Cloning and characterization of three     hemolysin genes from Aeromonas salmonicida. Microb. Pathog.     15 (1993) 269 282. -   Hofmann, K. and Stoffel, W.: TMbase—A database of membrane spanning     proteins segments. Biol. Chem. Hoppe-Seyler 347 (1993) 166. -   Hueck, C. J.: Type III protein secretion systems in bacterial     pathogens of animals and plants. Microbiol. Mol. Biol. Rev.     62 (1998) 379 433. -   Iriarte, M. and Cornelis, G. R.: Identification of SycN, YscX, and     YscY, three new elements of the Yersinia yop virulon. J. Bacteriol.     181 (1999) 675 680. -   Laemmli, U. K.: Cleavage of structural proteins during the assembly     of the head of bacteriophage T4. Nature 227 (1970) 680 685. -   Leary, S. E., Williamson, E. D., Griffin, K. F., Russell, P.,     Eley, S. M. and Titball, R. W.: Active immunization with recombinant     V antigen from Yersinia pestis protects mice against plague. Infect.     Immun. 63 (1995) 2854 2858. -   Lee, K. K. and Ellis, A. E.: Glycerophospholipid:cholesterol     acyltransferase complexed with lipopolysaccharide (LPS) is a major     lethal exotoxin and cytolysin of Aeromonas salmonicida: LPS     stabilizes and enhances toxicity of the enzyme. J. Bacteriol.     172 (1990) 5382 5393. -   Lupas, A., Van, D. M. and Stock, J.: Predicting coiled coils from     protein sequences. Science 252 (1991) 1162 1164. -   Michiels, T. and Cornelis, G. R.: Secretion of hybrid proteins by     the Yersinia Yop export system. J. Bacteriol. 173 (1991) 1677 1685. -   Motin, V. L., Nakajima, R., Smirnov, G. B. and Brubaker, R. R.:     Passive immunity to Yersiniae mediated by anti-recombinant V antigen     and protein A-V antigen fusion peptide. Infect. Immun. 62 (1994)     4192 4201. -   Munro, A. L. and Hastings, T. S.: Furunculoses. In Inglis, V.,     Roberts, R. J. and Bromage, N. R. (Eds.), Bacterial diseases of     fish. Blackwell Scientific, Oxford, 1993, pp. 122 142. -   Nilles, M. L., Fields, K. A. and Straley, S. C.: The V antigen of     Yersinia pestis regulates Yop vectorial targeting as well as Yop     secretion through effects on YopB and LcrG. J. Bacteriol. 180 (1998)     3410 3420. -   Nilles, M. L., Williams, A. W., Skrzypek, E. and Straley, S. C.:     Yersinia pestis LcrV forms a stable complex with LcrG and may have a     secretion-related regulatory role in the low-Ca²⁺ response. J.     Bacteriol. 179 (1997) 1307 1316. -   Pettersson, J., Holmstrom, A., Hill, J., Leary, S., Frithz-Lindsten,     E., Von Euler-Matell, A., Carlsson, E., Titball, R., Forsberg, A.     and Wolf-Watz, H.: The V-antigen of Yersinia is surface exposed     before target cell contact and involved in virulence protein     translocation. Mol. Microbiol. 32 (1999) 961 976. -   Pitcher, D. G., Saunders, N. A. and Owen, R. J.: Rapid extraction of     bacterial genomic DNA with guanidium thiocyanate. Lett. Appl.     Microbiol. 8 (1989) 151 156. -   Plano, G. V., Barve, S. S. and Straley, S. C.: LcrD, a     membrane-bound regulator of the Yersinia pestis low-calcium     response. J. Bacteriol. 173 (1991) 7293 7303. Price, S. B. and     Straley, S. C.: lcrH, a gene necessary for virulence of Yersinia     pestis and for the normal response of Y. pestis to ATP and calcium.     Infect. Immun. 57 (1989) 1491 1498. -   Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A.,     Wiener-Kronish, J. P. and Frank, D. W.: Active and passive     immunization with the Pseudomonas V antigen protects against type     III intoxication and lung injury [see comments]. Nat. Med 5 (1999)     392 398. -   Schaller, A., Kuhn, R., Kuhnert, P., Nicolet, J., Anderson, T. J.,     MacInnes, J. I., Segers, R. P. A. M. and Frey, J.: Characterization     of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.     Microbiology 145 (1999) 2105 2116. -   Skrzypek, E. and Straley, S. C.: LcrG, a secreted protein involved     in negative regulation of the low-calcium response in Yersinia     pestis. J. Bacteriol. 175 (1993) 3520 3528. -   Studier, F. W., Rosenberg, A. H., Dunn, J. J. and Dubendorff, J. W.:     Use of T7 RNA polymerase to direct expression of cloned genes.     Methods Enzymol. 185 (1990) 60 89. -   Thornton, J. C., Garduno, R. A., Carlos, S. J. and Kay, W. W.: Novel     antigens expressed by Aeromonas salmonicida grown in vivo. Infect.     Immun. 61 (1993) 4582 4589. -   Titball, R. W. and Munn, C. B.: The purification and some properties     of H-lysin from Aeromonas salmonicida. J. Gen. Microbiol. 131 (1985)     1603 1609. -   Whitby, P. W., Landon, M. and Coleman, G.: The cloning and     nucleotide sequence of the serine protease gene (aspA) of Aeromonas     salmonicida ssp. salmonicida. FEMS Microbiol. Lett. 78 (1992) 65 71. -   Yahr, T. L., Goranson, J. and Frank, D. W.: Exoenzyme S of     Pseudomonas aeruginosa is secreted by a type III pathway. Mol.     Microbiol. 22 (1996) 991 1003. -   Yahr, T. L., Mende-Mueller, L. M., Friese, M. B. and Frank, D. W.:     Identification of type III secreted products of the Pseudomonas     aeruginosa exoenzyme S regulon. J. Bacteriol. 179 (1997b) 7165 7168. -   Yahr, T. L., Mende-Mueller, L. M., Friese, M. B. and Frank, D. W.:     Identification of type III secreted products of the Pseudomonas     aeruginosa exoenzyme S regulon. J. Bacteriol. 179 (1997a) 7165 7168. 

1. A method for reducing the susceptibility of a fish to an infection by Aeromonas salmonicida, the method comprising administering to the fish at least one epitope or epitopic region of an Aeromonas salmonicida polypeptide selected from the group consisting of: Acr1, Acr2, Acr3, Acr4, AcrD, AcrR, AcrG, AcrV, and AcrH, wherein the fish is a salmonid.
 2. The method of claim 1, wherein the Aeromonas salmonicida polypeptide is AcrV.
 3. The method of claim 1, wherein the infection is a virulent strain of Aeromonas salmonicida.
 4. The method of claim 1, wherein administering comprises providing to the fish an immunogenic composition comprising the at least one epitope or epitopic region.
 5. The method of claim 4, wherein the immunogenic composition further comprises a pharmaceutically acceptable carrier.
 6. The method of claim 1, wherein the administering comprises intraperitoneal, intramuscular, intradermal, intracellular, spray, immersion, oral, or gill.
 7. A method for reducing the susceptibility of a fish to infection by Aeromonas salmonicida, the method comprising administering to the fish a polypeptide having an amino acid sequence selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9, wherein the fish is a salmonid.
 8. The method of claim 7, wherein the administering comprises intraperitoneal, intramuscular, intradermal, intracellular, spray, immersion, oral, or gill.
 9. The method of claim 7, wherein the infection is a virulent strain of Aeromonas salmonicida.
 10. The method of claim 7, wherein the amino acid sequence is SEQ ID NO:1.
 11. The method of claim 7, wherein administering comprises providing to the fish an immunogenic composition comprising the polypeptide.
 12. The method of claim 11, wherein the immunogenic composition further comprises a pharmaceutically acceptable carrier. 